rxstat › Shortages › Venlafaxine

Venlafaxine shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Venlafaxine products are in shortage in Canada (9 of 47 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 31, 2026.
Products affected
9 / 47
In shortage since
Jul 26, 2022
Est. full return
Dec 31, 2026
Reports on file
166
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
VENLAFAXINE XR
75MG · CAPSULE (EXTENDED RELEASE) · JAMP PHARMA CORPORATION
DIN 02516543 · since Jun 30, 2026, est. end Aug 28, 2026 · Disruption of the manufacture of the drug.
Active shortage
MINT-VENLAFAXINE XR
37.5MG · CAPSULE (EXTENDED RELEASE) · MINT PHARMACEUTICALS INC
DIN 02522977 · since Feb 6, 2026, est. end Dec 31, 2026 · Requirements related to complying with good manufacturing practices.
Active shortage
MINT-VENLAFAXINE XR
75MG · CAPSULE (EXTENDED RELEASE) · MINT PHARMACEUTICALS INC
DIN 02522985 · since Feb 6, 2026, est. end Dec 31, 2026 · Requirements related to complying with good manufacturing practices.
Active shortage
MINT-VENLAFAXINE XR
150MG · CAPSULE (EXTENDED RELEASE) · MINT PHARMACEUTICALS INC
DIN 02522993 · since Feb 6, 2026, est. end Dec 31, 2026 · Requirements related to complying with good manufacturing practices.
Active shortage
ACT VENLAFAXINE XR
75MG · CAPSULE (EXTENDED RELEASE) · TEVA CANADA LIMITED
DIN 02304325 · since Mar 10, 2026, est. end Jun 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
TARO-VENLAFAXINE XR
75MG · CAPSULE (EXTENDED RELEASE) · SUN PHARMA CANADA INC
DIN 02380080 · since Apr 13, 2026, est. end Jul 17, 2026 · Disruption of the manufacture of the drug.
Active shortage
TARO-VENLAFAXINE XR
75MG · CAPSULE (EXTENDED RELEASE) · SUN PHARMA CANADA INC
DIN 02380080 · since Nov 28, 2025, est. end Jul 17, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-VENLAFAXINE XR
37.5MG · CAPSULE (EXTENDED RELEASE) · APOTEX INC
DIN 02331683 · since Jun 20, 2023, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-VENLAFAXINE XR
37.5MG · CAPSULE (EXTENDED RELEASE) · APOTEX INC
DIN 02331683 · since May 9, 2023, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-VENLAFAXINE XR
150MG · CAPSULE (EXTENDED RELEASE) · APOTEX INC
DIN 02331705 · since Jul 26, 2022, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-VENLAFAXINE XR
75MG · CAPSULE (EXTENDED RELEASE) · APOTEX INC
DIN 02331691 · since Apr 18, 2023, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-VENLAFAXINE XR
150MG · CAPSULE (EXTENDED RELEASE) · APOTEX INC
DIN 02331705 · since Dec 13, 2022, no end estimate · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Venlafaxine is currently affected by 9 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, MINT PHARMACEUTICALS INC, TEVA CANADA LIMITED, SUN PHARMA CANADA INC and 1 others.

The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Venlafaxine is classified under “ANTIDEPRESSANTS” (ATC N06AX).

Recent changes

Common questions

When will Venlafaxine be back in stock in Canada?

The latest manufacturer estimate is Dec 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Venlafaxine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antidepressants)

Widespread shortageClomipramine3 of 4 reported products affected · est. return Jul 3, 2026Widespread shortageImipramine3 of 6 reported products affected · est. return Aug 28, 2026Partial shortageAmitriptyline15 of 34 reported products affected · est. return Jul 17, 2026Partial shortageBupropion3 of 15 reported products affected · est. return Jul 15, 2026Partial shortageCitalopram10 of 43 reported products affected · est. return Sep 30, 2026Partial shortageDesvenlafaxine2 of 17 reported products affected · est. return Jul 31, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.